-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

China Is In Talks With Pfizer For License To Manufacture And Distribute A Generic Version Of The U.S. Firm's Covid-19 Antiviral Drug Paxlovid In China; China Is Keen To Finalize Licensing Deal Terms Before The Lunar New Year Which Begins On Jan. 22

Benzinga · 01/06/2023 11:29

- Reuters